Haematological values in homozygous sickle cell disease in steady state and haemoglobin phenotypes AA controls in Lagos, Nigeria

BMC Research Notes

Olanrewaju Arogundade³  Phillip Adebola¹  Olajumoke Oshinaike¹  Adewumi Adediran²  Adedoyin Dosunmu³  Akinsegun Akinbami³ 

[1] Department of Medicine, Lagos State University, College of Medicine, Lagos, Nigeria;Department of Haematology and Blood Transfusion, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria;Department of Haematology and Blood Transfusion, Lagos State University, College of Medicine, Lagos, Nigeria

关键词: Haemoglobin phenotype AA;    Steady state;    Homozygous sickle cell disease;    Haematological values;   

Others  :  1166035
DOI  :  10.1186/1756-0500-5-396

 received in 2012-03-17, accepted in 2012-07-25,  发布年份 2012

【 摘 要 】

Background

Sickle cell disease is a genetic abnormality involving the haemoglobin. Although, it is primarily a red cell disorders, the white blood cells and platelets are also affected by the mutation. The consequent haemoglobin S causes polymerization of haemoglobin resulting in haemolysis and anaemia. This study aims to provide baseline haematological values in sickle cell disease patients in steady state and compare the deviation from haemoglobin phenotype AA control values.

Methods

A case–control study was conducted amongst homozygous sickle cell patients attending the sickle cell clinics of Lagos State University Teaching Hospital Ikeja and haemoglobin phenotype AA controls. About 4.5mls of blood sample was collected from each participant for full blood count analysis. All blood samples were screened for HIV and haemoglobin phenotypes confirmed using cellulose acetate haemoglobin electrophoresis at pH 8.6.

Results

A total of 103 cases and 98 controls were enrolled. The overall mean haemoglobin concentration for cases was 7.93 ± 1.47 g/dl, packed cell volume 24.44 ± 4.68%, mean cell volume 81.52 ± 7.89 fl, and mean cell haemoglobin 26.50 ± 3.20 pg. While for controls, mean haemoglobin concentration was 13.83 ± 1.32 g/dl, packed cell volume 43.07 ± 3.95%, mean cell volume 86.90 ± 4.69 fl, and mean cell haemoglobin 28.50 ± 1.34 pg. The overall mean white blood cell counts for the cases was 10.27 ± 3.94 *10³/μl and platelet counts of 412.71 ± 145.09*10³/μl. While white blood cell count for the controls was 5.67 ± 1.59*10³/μl and platelet counts of 222.82 ± 57.62*10³/μl.

Conclusion

Homozygous sickle cell disease patients have lower values of red cell parameters, but higher values of white cell and platelets counts compared to haemoglobin phenotype AA controls.

【 授权许可】

   
2012 Akinbami et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Test ST, Kleman K, Lubin B: Characterisation of the complement sensitivity of density-fractionated sickle cells. Blood 1991, 78(Suppl]):202a.
• [2]Allan D, Lumbrick AR, Thomas P, Westerman MP: Release of Spectrin-free Spicules on re- oxygenation of sickled erythrocytes. Nature 1982, 295(5850):612-613.
• [3]Platt OS: Exercise–induced haemolysis in Sickle cell anaemia: Shear sensitivity and erythrocyte dehydration. Blood 1982, 59(5):1055-1060.
• [4]Galili U, Clark MR, Shohat SB: Excessive binding of natural anti-alpha galactosyl immunoglobulin G to sickle erythrocytes may contribute to extravascular cell destruction. J Clin Invest 1986, 77(1):27-33.
• [5]Green GA, Kalra VK: Sickling-induced binding of immunoglobulin to sickle erythrocyte. Blood 1988, 71(3):636-639.
• [6]Kaul DK, Fabry ME, Nagel RL: Vaso-Occlusion by Sickle cells, evidence from selective trapping of dense red cells. Blood 1986, 68(5):1162-1166.
• [7]Serjeant GR, Serjeant BE, Milner PF: The irreversibly sickled cell, a determinant of haemolysis in sickle cell anaemias. Br J Haematol 1969, 17(6):527-533.
• [8]Noguchi CT, Schechter AN: Non-uniformity of intracellular polymer formation in sickle erythrocytes, possible correlation with severity of haemolytic anaemia. Annu. Rev. Biophys. Chen. 1985, 4:239.
• [9]Brittenham GM, Schechter AN, Noguchi CT: Haemoglobin S polymerization: primary determinant of the haemolytic and clinical severity of sickling syndromes. Blood 1985, 65(1):183-189.
• [10]Okpala IE: The management of crises in sickle cell disease (review). Eur J Haematol 1998, 68:1-6.
• [11]Attah EB, Ekere MC: Death patterns in sickle cell anaemia. JAMA 1987, 233:890-899.
• [12]Anyaegbu CC, Okpala IE, Aken’ova AY, Salimonu LS: Peripheral blood neutrophil count and candidacidal activity correlate with the clinical severity of sickle cell anaemia. Eur J Haematol 1998, 60:267-8.
• [13]Platt OS, Brambilla DJ, Rosse WF, et al.: Mortality in sickle cell disease-life expectancy and risk factors for early death. N Engl J Med 1994, 330:1639-1643.
• [14]Ohene-frempong K, Weiner SJ, Sleeper LA, et al.: Cerebrovascular accidents in sickle cell disease;rates and risk factors. Blood 1998, 91:288-294.
• [15]Powers DR: Management of cerebral vasculopathy in children with sickle cell anaemia. Br J Haematol 2000, 108:666-678.
• [16]Kinney TR, Sleeper LA, Wang WC, et al.: Silent cerebral infarcts in sickle cell anaemia: a risk factor analysis. Paediatrics; 1999, 103:640-645.
• [17]Castro O, Brambilla DJ, Thorington B, et al.: The acute chest syndrome of sickle cell disease; Incidence and risk factors. The co-operative study of sickle cell disease. Blood 1994, 84:643-645.
• [18]Okpala I: Steady-state platelet count and complications of sickle cell disease. The Haematology Journal 2002, 3:214-215.
• [19]Miller ST, Sleeper LA, Pegalow CH, et al.: Predictions of adverse outcomes in children with sickle cell disease; a report from the cooperative study (CSSCD). N Engl J Med 2000, 342:83-89.
• [20]Mehta P, Mehta J: Abnormalties of platelet aggregation in sickle cell disease. J Pediatr 1980, 96(2):209-213.
• [21]Arai H, Petchalai B, Khupulsup K, Kurimura T, Takeda K: Evaluation of Rapid Immunochromatographic Test for Detection of Antibodies to Human Immunodefficiency Virus. J Clin Microbiol 1999, 37(2):367-370.
• [22]Kaul DK, Fabry M, Windisch P, Baez S, Nagel R: Erythrocytes in sickle cell anaemia are heterogenous in their rheological and haemodynamic characteristics. J Clin Invest 1983, 72:22-31.
• [23]Milhorat AT: Leucocytosis during various emotional states. Arch Neurol Psych. 1942, 47:779.
• [24]Charache S, Terrin ML, Moore RD, et al.: Effect of hydroxyurea on the frequency of painful crises in sickle cell anaemia. N. Engl. Med 1995, 322:1314-1322.
• [25]Oloopoenia L, Fredrick W, Greaves W, Adams R, et al.: Pneumococcal sepsis and meningitis in adults with sickle cell disease. South Med J 1990, 83:1002-1004.
• [26]Sherwood JB, Goldwesser E, Chilcoat R, et al.: Sickle cell anaemia patients have low erythropoietin levels for their degree of anaemia. Blood 1987, 67:46-49.
• [27]Morris J, Dunn D, Beckford M, et al.: The haematology of homozygous sickle cell disease after 40. Br J Haematol 1991, 77:382-385.
• [28]Omoti CE: Haematological values in sickle cell anaemia in steady state and during vaso-occlusive crises in Benin city,Nigeria. Ann Afr Med 2005, 4(2):62-67.
• [29]Kraff-Jacobs B, Williams J, Soldin SJ: Plasma erythropoietin reference ranges in children. The journal of Paediatrics 1995, 126(4):601-603.
• [30]Hoffbrand AV, Lewis MS, Tuddenham ED: Postgraduate Haematology. 4th edition. Oxford University Press, Madison Avenue, New York Inc.; 2001:19.
• [31]Schwartz AD: The splenic platelet reservoir in sickle cell anaemia. Blood 1972, 40(5):678.